Asymmetric syntheses of biologically active heterocyclic natural products employing catalytic C-H activation strategy
Project/Area Number |
24590001
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Chemical pharmacy
|
Research Institution | University of Toyama |
Principal Investigator |
NAMBU Hisanori 富山大学, 大学院医学薬学研究部(薬学), 准教授 (80399956)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
Keywords | 複素環化合物 / C-H結合活性化 / 生物活性天然物 / C-H挿入反応 / 触媒反応 / ロジウム(II)錯体 / 不斉合成 / ジヒドロベンゾフラン / C-Hオレフィン化 / ロジウム(II)触媒 / ネオリグナン / スチルベンダイマー |
Outline of Final Research Achievements |
Asymmetric synthesis of (-)-trans-blechnic acid, a dihydrobenzofuran neolignan natural product, has been achieved by employing Rh(II)-catalyzed intramolecular C-H insertion reaction of aryldiazoacetate and Pd(II)-catalyzed intermolecular C-H olefination reaction as key steps. Asymmetric synthesis of (-)-E-δ-viniferin, a trans-resveratrol dimer natural product containing a dihydrobenzofuran ring, has been achieved by exploiting Rh(II)-catalyzed intramolecular C-H insertion reaction of a diaryldiazomethane derivative as a key step.
|
Report
(4 results)
Research Products
(16 results)